medigraphic.com
ISSN 1561-3194 (Electronic)

2016, Number 6

<< Back Next >>

Rev Ciencias Médicas 2016; 20 (6)

Clinical-epidemiological characterization of transfusions

Diaz PD, Melians ASM, Padrino GM, González FI, Urquiola MM

Language: Spanish
References: 22
Page: 698-706
PDF size: 222.36 Kb.


ABSTRACT

Introduction: blood transfusions can save or sustain a life; however, they are a transient treatment and should be considered as a tissue transplant with short and self-limiting life.
Objective: to assess the use of the indication of blood and its components at "Dr. León Cuervo Rubio" Hospital into the context of an adequate hemosurveillance.
Method: a descriptive, cross-sectional and retrospective study was carried out in which the requests for transfusion services were appraised, reviewing the monthly reports of the Hospital Transfusion Committee and the registry of transfusion adverse reactions due to blood components in each of the services during the year 2015.
Results: in the year 2015 there was a decrease in the number of transfused patients compared to 2014, despite having a higher number of admissions; 68.3% of transfused patients were old people and ages from 61 to 70. The erythrocyte concentration was the most used component and Internal Medicine service had more transfused patients. The reports of adverse reactions were higher in 2015; febrile non-hemolytictransfusion reactionwas more frequent.
Conclusions: efforts should be addressed towards the proper use of blood components, assessing the current trend to senescence and onco-hematological diseases. It is necessary to assess the risks and benefits of transfusions using a strict hemosurveillance system in hospitals to monitor and to report adverse reactions.


REFERENCES

  1. Naranjo MD. Evaluación del proceso de Transfusión del Banco de Sangre en el Hospital Metropolitano de Quito durante septiembre del 2008-Agosto del2009 [Tesis]. Universidad San Francisco de Quito, Colegio de Ciencias de la Salud. Quito, Ecuador; diciembre de 2009. Disponible en:http://repositorio.usfq.edu.ec/handle/23000/764

  2. Gammon HM, Walters JH, Watt A. Developing performance measure for patient blood management. Transfusion [Internet]. 2011 [citado 20 Jun 2016]; 51(11): [Aprox. 8p.]. Disponible en: http://onlinelibrary.wiley.com/doi/10.1111/j.1537-2995.2011.03406.x/full

  3. Carson Jl, Grossman BJ, Kleinman S, Tinmouth AT, Marques MB, Fung MK, et al. Red Blood cell transfusión: A Clinical Practice Guideline. From the AABB. Annals of Internal Medicine [Internet]. 2012 [citado 20 Jun 2016]; 157(1): [Aprox. 10p.]. Disponible en: http://annals.org/article.aspx?articleid=1206681

  4. Silva HM, Bencomo AA, López R, Benet M, Ballester JM. La hemovigilancia de las reacciones adversas a la donación de sangre. Rev Cubana HematolInmunolHemoter [Internet]. 2013 [citado 20 Jun 2016]; 29(2). Disponible en:http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892013000200006

  5. Gil M, García A, Romero A, Arias L, Prevot V, Sorá D. Epidemiología de las transfusiones en el Hospital Militar Central "Dr. Carlos J. Finlay" Rev Cubana HematolInmunolHemoter [Internet]. 2015 [citado 20 Jun 2016]; 31(4). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892015000400012

  6. Pérez Ulloa LE, Rubio Rubio R, Suárez Escandón A, Cádiz Lahens A, Ballester Santovenia JM. Breve análisis del comportamiento de la hemoterapia en Cuba en el año 2011. Rev Cubana HematolInmunolHemoter [Internet]. 2012 [citado 20 Jun 2016]; 28(4): [Aprox. 3p.]. Disponible en:http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892012000400013

  7. OPS-OMS. Plan de acción para el acceso universal de sangre segura. Washington DC: OPS; 2014.

  8. Silva HM. Programa de hemovigilancia para los servicios de salud de la Provincia de Matanzas [Tesis]. Villa Clara, Cuba: Universidad de Ciencias Médicas de Villa Clara; 2011. Disponible en:http://tesis.repo.sld.cu/436/

  9. Delgado MB. Transfusión sanguínea. Uso racional. RevColombAnestesiol [Internet]. 2012 citado 20 Jun 2016]; 40(4): [Aprox. 1p]. Disponible en: http://www.scielo.org.co/pdf/rca/v40n4/v40n4a01

  10. Martínez A, Rivero RA, Fernández N. Efectos adversos en la cadena transfusional en el Instituto de Hematología e Inmunología. Rev Cubana HematolInmunolHemoter [Internet]. 2015 Sep [citado 20 Jun 2016]; 31(3): [Aprox. 12p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892015000300007&lng=es

  11. Guralnik JM, Eisenstaedt RS, Ferrucci L. Prevalence of anemia in persons 65 years and older in the United States: evidence of a high rate of unexplained anemia. Blood [Internet]. 2004 [citado 20 Jun 2016]; 104: [Aprox. 5p.]. Disponible en:http://www.bloodjournal.org/content/104/8/2263.short?sso-checked=true

  12. Katalinic A, Peters E, Beske F. Projection of morbidity 2030 and 2050: impact for the national health system and blood supply. TransfusMedHemother [Internet].2010 [citado 20 Jun 2016]; 37(3): [Aprox. 4p.]. Disponible en:http://www.karger.com/Article/Abstract/313993

  13. Revelan datos preliminares del Censo de Población y Viviendas 2012. Granma. 2012 Diciembre 7; 7:38:14.

  14. De Vries RR, Faber JC. Hemovigilance: An Effective Tool for Improving Transfusion Safety. Amsterdam: Wiley-Blackwell; 2012.

  15. CarneiroProietti AB. Hemovigilance: a system to improve the whole transfusion chain. RevBrasHematolHemoter [Internet]. 2013 [citado 20 Jun 2016]; 35(3): [Aprox. 1p.]. Disponible en: http://www.scielo.br/scielo.php?pid=S1516-84842013000300158&script=sci_arttext&tlng=es

  16. El Uso Clínico de la Sangre en Medicina General Obstetricia Pediatría y Neonatología Cirugía y Anestesia Trauma y Quemaduras. Ginebra: Organización Mundial de la Salud; s/a.

  17. Bagang E, Szallasi A. "Transfusion indication RBC (PBM-02)": gap analysis of a Joint Commission Patient Blood Management Performance Measure at a community hospital. BloodTransfus [Internet]. 2014 [citado 20 Jun 2016]; 12(Suppl-1): [Aprox. 2p.]. Disponible en:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3934221/

  18. Organización Mundial de la Salud. Base Mundial de Datos sobre Seguridad de la Sangre [Internet]. 2011 [citado 20 Jun 2016]. Disponible en: http://www.who.int/bloodsafety/global_database/GDBS_Summary_Report_2011.pdf?ua=1

  19. 19.Alhetheel A, El-Hazmi MM. Hepatitis G virus in Saudi blood donors and chronic hepatitis B and C patients.J InfectDevCtries [Internet]. 2014 Jan-15 [citado 20 Jun 2016]; 8(1): [Aprox. 5p.]. Disponible en::https://www.ncbi.nlm.nih.gov/pubmed/24423720

  20. Isbister JP, Shander A, Spahn DR. Adverse blood transfusion outcomes: establishing causation. TransfusMedRev [Internet]. 2011 [citado 20 Jun 2016]; 25(2): [Aprox. 3p.]. Disponible en: http://www.sciencedirect.com/science/article/pii/S0887796310000829

  21. Kumar P, Thapliyal R, Coshic P, Chatterjee K. Retrospective evaluation of adverse transfusion reactions following blood product transfusion from a tertiary care hospital: A preliminary step towards hemovigilance. Asian J TransfusSci [Internet]. 2013 Jul [citado 20 Jun 2016]; 7(2): [Aprox. 6p.]. Disponible en: http://www.sciencedirect.com/science/article/pii/S0887796310000829

  22. Fernandez Y, Cedré T, Zamora L. Reacciones adversas postransfusionales a componentes sanguíneos. Rev Cubana Farm [Internet].2004 [citado 20 Jun 2016]; 38(2). Disponible en:http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75152004000200008




2020     |     www.medigraphic.com